Science Explorer Back to mapMap
Discussion
Company · Marseille · France

Genoscience Pharma (France)

genosciencepharma.com/enROR OpenAlex
Research works
45
▲ 235% vs 2018-21
Citations
517
11.5 per fractional work
Top-10% rate
5.0%
all institutions 10.0%
Open access
65%
world 40%
International
42%
world 18%
Genoscience Pharma (France)

Not ranked overall: Genoscience Pharma (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Genoscience Pharma (France) work in?

In 2022-now, 40% of research at Genoscience Pharma (France) is in Life Sciences, 38% in Health Sciences. Its largest fields are Medicine (35%), Immunology and Microbiology (17%), Biochemistry, Genetics and Molecular Biology (17%). It does 2.0× the world's share of Life Sciences.

Life Sciences: 9 fractional works · 40.4% of its workImmunology and Microbiology: 4 fractional works · 17.1% of its workImmunology: 2 fractional works · 9.9% of its workParasitology: 2 fractional works · 7.2% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 16.8% of its workMolecular Biology: 2 fractional works · 8.5% of its workGenetics: 1 fractional works · 2.7% of its workCancer Research: 0 fractional works · 2.2% of its workBiophysics: 0 fractional works · 1.5% of its workBiotechnology: 0 fractional works · 1.5% of its workCell Biology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 3.6% of its workPharmaceutical Science: 1 fractional works · 3.1% of its workPharmacology: 0 fractional works · 0.5% of its workAgricultural and Biological Sciences: 0 fractional works · 2.0% of its workInsect Science: 0 fractional works · 1.5% of its workPlant Science: 0 fractional works · 0.5% of its workNeuroscience: 0 fractional works · 0.9% of its workCognitive Neuroscience: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.3% of its workSensory Systems: 0 fractional works · 0.3% of its workHealth Sciences: 8 fractional works · 37.7% of its workMedicine: 8 fractional works · 35.4% of its workPublic Health, Environmental and Occupational Health: 3 fractional works · 11.9% of its workOncology: 1 fractional works · 4.4% of its workEpidemiology: 1 fractional works · 3.2% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.9% of its workPulmonary and Respiratory Medicine: 0 fractional works · 2.2% of its workInfectious Diseases: 0 fractional works · 1.9% of its workReproductive Medicine: 0 fractional works · 1.5% of its workRheumatology: 0 fractional works · 1.5% of its workNeurology: 0 fractional works · 0.9% of its workSurgery: 0 fractional works · 0.8% of its workDermatology: 0 fractional works · 0.8% of its workPathology and Forensic Medicine: 0 fractional works · 0.7% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.5% of its workPhysiology: 0 fractional works · 0.5% of its workGenetics: 0 fractional works · 0.4% of its workHepatology: 0 fractional works · 0.4% of its workGastroenterology: 0 fractional works · 0.4% of its workUrology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 1.5% of its workEmergency Medical Services: 0 fractional works · 0.8% of its workSpeech and Hearing: 0 fractional works · 0.8% of its workDentistry: 0 fractional works · 0.9% of its workPeriodontics: 0 fractional works · 0.6% of its workOral Surgery: 0 fractional works · 0.3% of its workPhysical Sciences: 3 fractional works · 12.8% of its workComputer Science: 2 fractional works · 7.9% of its workComputational Theory and Mathematics: 1 fractional works · 3.7% of its workComputer Vision and Pattern Recognition: 1 fractional works · 2.7% of its workComputer Networks and Communications: 0 fractional works · 0.8% of its workInformation Systems: 0 fractional works · 0.8% of its workMathematics: 1 fractional works · 2.4% of its workModeling and Simulation: 0 fractional works · 1.4% of its workStatistics and Probability: 0 fractional works · 1.0% of its workChemistry: 0 fractional works · 1.4% of its workOrganic Chemistry: 0 fractional works · 1.4% of its workEngineering: 0 fractional works · 0.9% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.8% of its workMedia Technology: 0 fractional works · 0.2% of its workMaterials Science: 0 fractional works · 0.2% of its workSocial Sciences: 2 fractional works · 9.0% of its workSocial Sciences: 2 fractional works · 6.7% of its workSociology and Political Science: 2 fractional works · 6.7% of its workBusiness, Management and Accounting: 0 fractional works · 2.2% of its workMarketing: 0 fractional works · 2.2% of its workALL ITS WORKGenosciencePharma (France)22fractional works, 2022-now
Life Sciences40%Physical Sciences13%Health Sciences38%Social Sciences9%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Immunology and Microbiology417.1%
    2. Biochemistry, Genetics and Molecular Biology416.8%
    3. Pharmacology, Toxicology and Pharmaceutics13.6%
    4. Agricultural and Biological Sciences02.0%
    5. Neuroscience00.9%
    1. Medicine835.4%
    2. Health Professions01.5%
    3. Dentistry00.9%
    1. Computer Science27.9%
    2. Mathematics12.4%
    3. Chemistry01.4%
    4. Engineering00.9%
    5. Materials Science00.2%
    1. Social Sciences26.7%
    2. Business, Management and Accounting02.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.42× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.15× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 16.99× its world share, 4 worksImmunology and Micro…Neuroscience: 0.55× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 10.39× its world share, 1 worksPharmacology, Toxico…Chemistry: 0.91× its world share, 0 worksChemistryComputer Science: 1.01× its world share, 2 worksComputer ScienceEngineering: 0.06× its world share, 0 worksEngineeringMaterials Science: 0.05× its world share, 0 worksMaterials ScienceMathematics: 2.02× its world share, 0 worksMathematicsDentistry: 1.80× its world share, 0 worksDentistryHealth Professions: 0.57× its world share, 0 worksHealth ProfessionsMedicine: 1.84× its world share, 8 worksMedicineBusiness, Management and Accounting: 0.70× its world share, 0 worksBusiness, Management…Social Sciences: 0.53× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 17.0×. Every wedge is a field page.

All 15 fields, with their numbers
  1. Immunology and Microbiology16.99×4 works
  2. Pharmacology, Toxicology and Pharmaceutics10.39×1 works
  3. Biochemistry, Genetics and Molecular Biology3.15×4 works
  4. Mathematics2.02×0 works
  5. Medicine1.84×8 works
  6. Dentistry1.80×0 works
  7. Computer Science1.01×2 works
  8. Chemistry0.91×0 works
  9. Business, Management and Accounting0.70×0 works
  10. Health Professions0.57×0 works
  11. Neuroscience0.55×0 works
  12. Social Sciences0.53×2 works
  13. Agricultural and Biological Sciences0.42×0 works
  14. Engineering0.06×0 works
  15. Materials Science0.05×0 works

Who are the top researchers at Genoscience Pharma (France)?

Ranked on the quality score, Eloïne Bestion, Madani Rachid and V. V. Chmil lead among researchers whose main affiliation is Genoscience Pharma (France).

  1. 1 Eloïne Bestion France · #1,077,147 worldwide 788 citations · 20 works
  2. 2 Madani Rachid France · #2,681,329 worldwide 255 citations · 16 works
  3. 3 V. V. Chmil France · #4,691,770 worldwide 6 citations · 16 works
  4. 4 Mohamed Moumaris France · #5,147,036 worldwide 110 citations · 21 works
All ranked researchers at Genoscience Pharma (France)

What are the most cited papers from Genoscience Pharma (France)?

The most cited paper from Genoscience Pharma (France) is "Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis" (Asma Fatima Boumaza, Laëtitia Gay, Soraya Mezouar et al., 2021), with 183 citations. Next come "Dose-Ranging and Cohort-Expansion Study of Monalizumab (IPH2201) in Patients with Advanced Gynecologic Malignancies: A Trial of the Canadian Cancer Trials Group (CCTG): IND221" (93) and "GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions" (91).

Most cited papers
#PaperReleasedCitations
1 Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis Asma Fatima Boumaza, Laëtitia Gay, Soraya Mezouar et al. · The Journal of Infectious Diseases Open access 23 Jan 2021 183
2 Dose-Ranging and Cohort-Expansion Study of Monalizumab (IPH2201) in Patients with Advanced Gynecologic Malignancies: A Trial of the Canadian Cancer Trials Group (CCTG): IND221 Anna V. Tinker, Holger W. Hirte, Diane Michele Provencher et al. · Clinical Cancer Research 15 Jul 2019 93
3 GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions Sonia Brun et al. · Autophagy Open access 5 Nov 2021 91
4 Avocado/soya unsaponifiables enhance the expression of transforming growth factor ?1 and ?2 in cultured articular chondrocytes Karim Boumédiene, Nathalie Félisaz, Patrick Bogdanowicz et al. · Arthritis & Rheumatism 1999 78
5 Application of the Kozeny Equation to Consolidated Porous Media M. R. J. Wyllie, Walter D. Rose · Nature 17 Jun 1950 61
All 74 most cited papers, with filters and sorting

Which keywords describe research at Genoscience Pharma (France)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Epidemiology, Pathogen Transmission, Vaccine Development, Public Health, Global Burden, Artemisinin Resistance, Plasmodium falciparum and Lyme Disease.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 14 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 14 words, with their numbers
  1. Epidemiology5▲ 5.2×13 topics
  2. Pathogen Transmission2▲ 142×2 topics
  3. Public Health2▲ 6.8×4 topics
  4. Global Burden2▲ 17×2 topics
  5. Vaccine Development2▲ 37×3 topics
  6. Artemisinin Resistance2▲ 274×1 topic
  7. Plasmodium falciparum2▲ 274×1 topic
  8. Machine Learning2▲ 2.5×6 topics
  9. Lyme Disease2▲ 294×1 topic
  10. Tick-Borne Diseases2▲ 294×1 topic
  11. Decentralization1▲ 25×2 topics
  12. Monoclonal Antibodies1▲ 58×3 topics
  13. Democratization1▲ 68×1 topic
  14. Indonesia1▲ 10×1 topic

Which research topics does Genoscience Pharma (France) publish most on?

By volume in 2022-now: Malaria Research and Control, Vector-borne infectious diseases, Asian Studies and History and Zoonotic diseases and public health.

Malaria Research and Con…2Malaria Research and Control: 2 fractional worksVector-borne infectious diseases: 2 fractional worksAsian Studies and History: 1 fractional worksZoonotic diseases and public health: 1 fractional worksAdvanced Drug Delivery Systems: 0 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksDigital Marketing and Social Media: 0 fractional worksDigital Imaging for Blood Diseases: 0 fractional worksConsumer Market Behavior and Pricing: 0 fractional worksComputational Drug Discovery Methods: 0 fractional works
Public Health, Environmental and Occupational HealthParasitologySociology and Political SciencePharmaceutical Science4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Malaria Research and Control Public Health, Environmental and Occupational Health 2 works
  2. 2 Vector-borne infectious diseases Parasitology 2 works
  3. 3 Asian Studies and History Sociology and Political Science 1 works
  4. 4 Zoonotic diseases and public health Public Health, Environmental and Occupational Health 1 works
  5. 5 Advanced Drug Delivery Systems Pharmaceutical Science 0 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  7. 7 Digital Marketing and Social Media Sociology and Political Science 0 works
  8. 8 Digital Imaging for Blood Diseases Computer Vision and Pattern Recognition 0 works
  9. 9 Consumer Market Behavior and Pricing Marketing 0 works
  10. 10 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available65.0%not open35.0%

World: 40% of research is openly available.

with international co-authors42.5%domestic only57.5%

World: 18% is written across borders.

How has Genoscience Pharma (France)'s research output changed?

Output in 2022-2025 was 235% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Genoscience Pharma (France) as a percentage of every work published that year, 0.00013% in 2024.

still counting0.00020%0.00040%Genoscience Pharma (France)0.000083% in 202519801990200020102020

Fractional works of Genoscience Pharma (France) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Marseille

All research institutions in Marseille

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Genoscience Pharma (France). Posts are plain text and can be reported.